Preventive Effects of Different Volumes of High-Intensity Interval Training on Risk Factors for MS in Overweight Young Women

October 28, 2024 updated by: Beijing Sport University

Preventive Effects of Different Volumes of High-Intensity Interval Training on Risk Factors for Metabolic Syndrome in Overweight Young Women

This study investigates the effects of different volumes of high-intensity interval training on risk factors for metabolic syndrome in overweight young women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The sedentary and inactive female overweight subjects, aged 18 to 30 years, were randomly divided into three groups: high volume high-intensity interval training group (4HIIT group), low volume high-intensity interval training group (1HIIT group) and control group (CON group). Human morphological measures, blood pressure, insulin resistance, blood analysis, and cardiorespiratory fitness were measured at baseline and after exercise intervention.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Beijing, China
        • School of Sports Medicine and Rehabilitation, Beijing Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women aged 18-30 years;
  • BMI≥24kg/m2, indicating overweight and high risk of metabolic syndrome;
  • Maintaining a stable body weight for the three months prior to the study.

Exclusion Criteria:

  • Regular participation in physical exercise (≥3 times/week, exercise time≥30min/time);
  • Any respiratory, musculoskeletal, or cardiovascular diseases;
  • Medical or other contraindications for exercise;
  • Taking medications that affect metabolism;
  • Smoking and/or drinking habits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Active Comparator: 1HIIT group
Behavioral: one HIIT
one HIIT high intensity interval training
Active Comparator: 4HIIT group
Behavioral: four HIIT
four HIIT high intensity interval training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 8 weeks
Changes in Weight before and after intervention.
8 weeks
Body Mass Index (BMI)
Time Frame: 8 weeks
Changes in BMI before and after intervention.
8 weeks
body fat percentage
Time Frame: 8 weeks
Changes in body fat percentage before and after intervention.
8 weeks
waist circumference (WC)
Time Frame: 8 weeks
Changes in WC before and after intervention.
8 weeks
Systolic blood pressure (SBP)
Time Frame: 8 weeks
Changes in SBP before and after intervention.
8 weeks
Diastolic blood pressure (DBP)
Time Frame: 8 weeks
Changes in DBP before and after intervention.
8 weeks
Fasting plasma glucose (FPG)
Time Frame: 8 weeks
Changes in FPG before and after intervention.
8 weeks
Triglyceride (TG)
Time Frame: 8 weeks
Changes in TG before and after intervention.
8 weeks
High-density lipoprotein cholesterol (HDL-C)
Time Frame: 8 weeks
Changes in HDL-C before and after intervention.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non high-density lipoprotein cholesterol (Non HDL-C)
Time Frame: 8 weeks
Changes in HDL-C before and after intervention.
8 weeks
Insulin
Time Frame: 8 weeks
Changes in insulin before and after intervention.
8 weeks
Homeostatic model assessment for insulin resistance (HOMA-IR)
Time Frame: 8 weeks
12、Homeostatic model assessment for insulin resistance (HOMA-IR) Changes in HOMA-IR before and after intervention.
8 weeks
Triglyceride-glucose (TyG) index
Time Frame: 8 weeks
Changes in TyG index before and after intervention.
8 weeks
Triglyceride-to-high density lipoprotein cholesterol ratio (TG/HDL-C ratio)
Time Frame: 8 weeks
Changes in TG/HDL-C ratio before and after intervention.
8 weeks
Visceral fat area (VFA)
Time Frame: 8 weeks
Changes in VFA before and after intervention.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beijing Sport University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2021

Primary Completion (Actual)

July 30, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

October 28, 2024

First Submitted That Met QC Criteria

October 28, 2024

First Posted (Actual)

October 29, 2024

Study Record Updates

Last Update Posted (Actual)

October 29, 2024

Last Update Submitted That Met QC Criteria

October 28, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PEDVHIITRFMOYW

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on one HIIT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe